Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ocean Biomedical

0.0082
+0.00033.67%
Volume:1.61M
Turnover:12.98K
Market Cap:1.36M
PE:-0.02
High:0.0087
Open:0.0081
Low:0.0073
Close:0.0079
Loading ...

Company Profile

Company Name:
Ocean Biomedical
Exchange:
PINK
Establishment Date:
2019
Employees:
7
Office Location:
55 Claverick Street,Room 325,Providence,Rhode Island,United States
Zip Code:
02903
Fax:
- -
Introduction:
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP. The company is based in Providence, Rhode Island. Ocean Biomedical, Inc. operates as a subsidiary of Poseidon Bio, LLC.